ArticleThe American journal of case reports2022
Pituitary Carcinoma in a Patient with Cowden Syndrome.
Article in The American journal of case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Differential expression of PTEN, pAKT1, pRPS6, and mismatch repair proteins in pituitary neuroendocrine tumors.Virchows Archiv : an international journal of pathology · 2026Article
- Clinical features of pituitary carcinoma: analysis based on a case report and literature review.Frontiers in endocrinology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Pituitary carcinomas are rare tumors that are histologically indistinguishable from pituitary adenoma. This report describes an extremely rare case of pituitary carcinoma in a patient with clinically diagnosed Cowden syndrome (CS). CS is a rare multisystemic hereditary disease with increase risks of cancer and benign overgrowth of different types of tissues. CASE REPORT A 52-year-old woman with history of CS presented with pituitary adenoma and multiple meningiomata. After surgical resection, there was recurrence of the pituitary tumor. Partial resection of the recurrent pituitary tumor revealed an adenoma. Radiotherapy was administered due to the histopathological aggressive features of the resected pituitary tumor and growth of the residual pituitary tumor on follow-up. Although the pituitary tumor shrank after radiotherapy, there was development of multiple new intracranial extra-axial lesions, including meningiomata. Resection of a rapidly growing extra-axial tumor in the parietal convexity region was performed. Given the similar histopathological features of the convexity tumor with the prior pituitary specimen, the diagnosis of pituitary carcinoma was established. A subsequent MRI scan showed metastatic deposits along the spine. The patient's condition deteriorated and she died shortly after the last surgery. CONCLUSIONS To the best of our knowledge, there is no prior report of pituitary carcinoma in a patient with CS in the literature. Pituitary carcinomas frequently spread within the craniospinal axis, in addition to hematogenous dissemination. Given the high risks of developing malignant tumors in patients with CS, multidisciplinary management including diagnostic imaging and close surveillance are of paramount importance in patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.